Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT03546387
Conditions
Pediatric Retinoblastoma
Retinoblastoma
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V)
California Verbal Learning Test, Children's Version
Beery Developmental Test of Visual Motor Integration, 6th edition
Grooved Pegboard Test
Behavior Assessment System for Children/Parent Report
Brief summary:
Conditions
Pediatric Retinoblastoma
Retinoblastoma
Study ID
NCT03546387
Start date
May 7, 2018
Status verified date
Jun, 2026
Completion date
May 7, 2027
Anticipated
Primary completion date
May 7, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Enrollment
75 participants
Anticipated
Interventions
Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V)
California Verbal Learning Test, Children's Version
Beery Developmental Test of Visual Motor Integration, 6th edition
Grooved Pegboard Test
Behavior Assessment System for Children/Parent Report
Primary outcome measure
Central contacts
Locations
Memorial Sloan Kettering Cancer Center
Recruiting
New York, New York, United States, 10065
Contacts
Vittoria Arslan Carlon, MD
212-639-2680Sponsor
Memorial Sloan Kettering Cancer Center
Last update posted
Jun 3, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-06-03.